U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): AUGUST 25, 2003
AMAZING NUTRITIONALS, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
000-50555 74-3046548
---------------- --------------------
(Commission File No.) (IRS Employer Identification No.)
43 West 33rd Street
Suite 405
New York, NY 10001
(212) 695-3334
(Address and telephone number of principal executive offices and place of
business)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below)
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13ed-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS:
APPOINTMENT OF PRINCIPAL OFFICERS
Effective, March 7, 2005, C.J. Lieberman resigned as Chairman of the Board of
Directors of the registrant
Mr. Lieberman did not state that his resignation does in any way imply or infer
that there is any dispute or disagreement relating to the Company's operations,
policies or practices.
Mr. Lieberman has been provided a copy of his disclosure, no less that the day
the Registrant is filing the disclosure with the Commission. Mr. Lieberman will
be given an opportunity to furnish the Registrant a letter or response, that he
agrees with the statements made by the Registrant in this Section 5.02, and if
not, stating the respects in which he does not agree. The registrant will file
by amendment, any such letter or response so received within two business days
after receipt.
ITEM 9. FINANCIAL STATEMENTS AND EXHIBITS
Financial Statements
(a) Financial Statements. N/A
(b) Pro Forma financial information. N/A
(c) Exhibits
Exhibit 17. Resignation Letter from C.J. Lieberman
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: March 15, 2005
AMAZING NUTRITIONALS, INC.
By: Barry Clare
------------------------
Barry Clare, President